New double chin injection enters human testing
NCT ID NCT06756490
First seen Mar 14, 2026 · Last updated May 13, 2026 · Updated 11 times
Summary
This early-stage study tests a new drug called HY-2003, which is a fat-dissolving injection for people with moderate to severe double chin. About 30 adults aged 18 to 65 will receive either the new drug, an existing treatment, or a placebo. The main goal is to check safety and how well the drug works at different doses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE OR SEVERE SUBMENTAL FULLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Email: •••••@•••••
-
The First Affiliated Hospital of Xi'an Jiaotong University
RECRUITINGXi'an, Shaanxi, 710061, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.